Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORE8394 in advanced solid tumors
NCT02428712Phase 2Completed
- Sponsor
- Fore Biotherapeutics
- Start
- Apr 2015
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plixorafenib in solid tumor, sponsored by Fore Biotherapeutics. Started Apr 2015; status: completed.
02
Drugs
plixorafenib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02428712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428712.